Full Course Description


Module 1: Using Neuroscience in the Treatment of Anxiety

Watch neuroscience and anxiety expert, Dr. Catherine Pittman, and learn her keys for successful anxiety treatment. Dr. Pittman integrates brain-based strategies for calming the anxious mind with client communication techniques that motivate change in your clients. Catherine’s approach promotes adherence to treatment and strengthens the therapeutic alliance - which is essential when working with anxious, worried, traumatized, or obsessive clients.

Dr. Pittman will give you proven tools and techniques to:

From this transformational workshop put the power of neuroplasticity to work for you and your anxious clients!

Program Information

Objectives

  1. Explain to clients the neurological processes underlying anxiety in a clearly understandable manner that enhances client motivation.
  2. Incorporate personalized goals to increase client engagement and focus client efforts on making lasting changes in the brain.
  3. Characterize the differences between amygdala-based and cortex-based anxiety symptoms in order to select the most effective treatment interventions.
  4. Individualize practical and evidence-based methods to resist anxiety and improve symptom management in clients.
  5. Teach strategies for calming the amygdala without use of medication to improve client level of functioning.
  6. Recommend exposure-based strategies that change the amygdala responses to triggers to reduce anxiety symptoms.
  7. Employ a variety of strategies to improve clinical outcomes utilizing evidence-based strategies that target cortex-based responding, including cognitive restructuring, psychoeducation, cognitive defusion, distraction, and mindfulness.
  8. Differentiate symptom-producing cognitions characteristic of specific disorders, including Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder as it relates to case conceptualization.
  9. Relate the clinical implications of how SSRIs and SNRIs promote the process of treating anxiety.
  10. Identify detrimental effects of benzodiazepines as it relates to anxiety treatment outcomes.
  11. Differentiate between rebound anxiety and relapse symptoms to inform the clinician’s choice of treatment interventions.
  12. Breakdown the key elements of mindfulness practices in managing symptoms of anxiety.
  13. Present client education exercises that can be utilized in session to train clients in the use of mindfulness techniques.
  14. Recognize common reactions to aversion and utilize clinical strategies to replace them with mindfulness.
  15. Reframe exposure as an opportunity to teach the amygdala new responses in order to improve client engagement and treatment compliance.
  16. Utilize clinical strategies for exposure that reduce avoidance and train clients to push through anxiety.
  17. Employ effective strategies for reducing anxiety symptoms utilizing imaginal and in vivo exposure, including use of SUDS and attention to interceptive triggers.
  18. Provide clinical strategies for managing comorbid depression that reduce worry, rumination, and common cognitive errors while promoting positive thinking and social interaction.
  19. Use cognitive restructuring and cognitive strategies for managing symptoms of OCD and GAD that focus on scheduling obsession/worries and promote client acceptance of uncertainty.
  20. Implement interventions in a clinical setting that use a reconsolidation approach to reactivate a symptom-producing memory and disconfirm it.

Outline

Module 1: Using Neuroscience in the Treatment of Anxiety

Module 2: Working with the Amygdala Module 3: Managing the Cortex Module 4: Medications in the Treatment of Anxiety Module 5: Exposure Strategies for Teaching the Amygdala Module 6: Mindfulness in the Anxious Brain Module 7: Neuropsychologically Informed CBT Module 8: Treating Comorbid Depression

Module 9: Cognitive Restructuring Interventions

Module 10: Using Reconsolidation Approaches

Copyright : 06/30/2018

Module 2: Working with the Amygdala

Program Information

Objectives

  1. Explain to clients the neurological processes underlying anxiety in a clearly understandable manner that enhances client motivation.
  2. Incorporate personalized goals to increase client engagement and focus client efforts on making lasting changes in the brain.
  3. Characterize the differences between amygdala-based and cortex-based anxiety symptoms in order to select the most effective treatment interventions.
  4. Individualize practical and evidence-based methods to resist anxiety and improve symptom management in clients.
  5. Teach strategies for calming the amygdala without use of medication to improve client level of functioning.
  6. Recommend exposure-based strategies that change the amygdala responses to triggers to reduce anxiety symptoms.
  7. Employ a variety of strategies to improve clinical outcomes utilizing evidence-based strategies that target cortex-based responding, including cognitive restructuring, psychoeducation, cognitive defusion, distraction, and mindfulness.
  8. Differentiate symptom-producing cognitions characteristic of specific disorders, including Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder as it relates to case conceptualization.
  9. Relate the clinical implications of how SSRIs and SNRIs promote the process of treating anxiety.
  10. Identify detrimental effects of benzodiazepines as it relates to anxiety treatment outcomes.
  11. Differentiate between rebound anxiety and relapse symptoms to inform the clinician’s choice of treatment interventions.
  12. Breakdown the key elements of mindfulness practices in managing symptoms of anxiety.
  13. Present client education exercises that can be utilized in session to train clients in the use of mindfulness techniques.
  14. Recognize common reactions to aversion and utilize clinical strategies to replace them with mindfulness.
  15. Reframe exposure as an opportunity to teach the amygdala new responses in order to improve client engagement and treatment compliance.
  16. Utilize clinical strategies for exposure that reduce avoidance and train clients to push through anxiety.
  17. Employ effective strategies for reducing anxiety symptoms utilizing imaginal and in vivo exposure, including use of SUDS and attention to interceptive triggers.
  18. Provide clinical strategies for managing comorbid depression that reduce worry, rumination, and common cognitive errors while promoting positive thinking and social interaction.
  19. Use cognitive restructuring and cognitive strategies for managing symptoms of OCD and GAD that focus on scheduling obsession/worries and promote client acceptance of uncertainty.
  20. Implement interventions in a clinical setting that use a reconsolidation approach to reactivate a symptom-producing memory and disconfirm it.

Outline

Module 2: Working with the Amygdala

 

Copyright : 06/30/2018

Module 3: Managing the Cortex

Program Information

Objectives

  1. Explain to clients the neurological processes underlying anxiety in a clearly understandable manner that enhances client motivation.
  2. Incorporate personalized goals to increase client engagement and focus client efforts on making lasting changes in the brain.
  3. Characterize the differences between amygdala-based and cortex-based anxiety symptoms in order to select the most effective treatment interventions.
  4. Individualize practical and evidence-based methods to resist anxiety and improve symptom management in clients.
  5. Teach strategies for calming the amygdala without use of medication to improve client level of functioning.
  6. Recommend exposure-based strategies that change the amygdala responses to triggers to reduce anxiety symptoms.
  7. Employ a variety of strategies to improve clinical outcomes utilizing evidence-based strategies that target cortex-based responding, including cognitive restructuring, psychoeducation, cognitive defusion, distraction, and mindfulness.
  8. Differentiate symptom-producing cognitions characteristic of specific disorders, including Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder as it relates to case conceptualization.
  9. Relate the clinical implications of how SSRIs and SNRIs promote the process of treating anxiety.
  10. Identify detrimental effects of benzodiazepines as it relates to anxiety treatment outcomes.
  11. Differentiate between rebound anxiety and relapse symptoms to inform the clinician’s choice of treatment interventions.
  12. Breakdown the key elements of mindfulness practices in managing symptoms of anxiety.
  13. Present client education exercises that can be utilized in session to train clients in the use of mindfulness techniques.
  14. Recognize common reactions to aversion and utilize clinical strategies to replace them with mindfulness.
  15. Reframe exposure as an opportunity to teach the amygdala new responses in order to improve client engagement and treatment compliance.
  16. Utilize clinical strategies for exposure that reduce avoidance and train clients to push through anxiety.
  17. Employ effective strategies for reducing anxiety symptoms utilizing imaginal and in vivo exposure, including use of SUDS and attention to interceptive triggers.
  18. Provide clinical strategies for managing comorbid depression that reduce worry, rumination, and common cognitive errors while promoting positive thinking and social interaction.
  19. Use cognitive restructuring and cognitive strategies for managing symptoms of OCD and GAD that focus on scheduling obsession/worries and promote client acceptance of uncertainty.
  20. Implement interventions in a clinical setting that use a reconsolidation approach to reactivate a symptom-producing memory and disconfirm it.

Outline

Module 3: Managing the Cortex

Copyright : 06/30/2018

Module 4: Medications in the Treatment of Anxiety

Program Information

Objectives

  1. Explain to clients the neurological processes underlying anxiety in a clearly understandable manner that enhances client motivation.
  2. Incorporate personalized goals to increase client engagement and focus client efforts on making lasting changes in the brain.
  3. Characterize the differences between amygdala-based and cortex-based anxiety symptoms in order to select the most effective treatment interventions.
  4. Individualize practical and evidence-based methods to resist anxiety and improve symptom management in clients.
  5. Teach strategies for calming the amygdala without use of medication to improve client level of functioning.
  6. Recommend exposure-based strategies that change the amygdala responses to triggers to reduce anxiety symptoms.
  7. Employ a variety of strategies to improve clinical outcomes utilizing evidence-based strategies that target cortex-based responding, including cognitive restructuring, psychoeducation, cognitive defusion, distraction, and mindfulness.
  8. Differentiate symptom-producing cognitions characteristic of specific disorders, including Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder as it relates to case conceptualization.
  9. Relate the clinical implications of how SSRIs and SNRIs promote the process of treating anxiety.
  10. Identify detrimental effects of benzodiazepines as it relates to anxiety treatment outcomes.
  11. Differentiate between rebound anxiety and relapse symptoms to inform the clinician’s choice of treatment interventions.
  12. Breakdown the key elements of mindfulness practices in managing symptoms of anxiety.
  13. Present client education exercises that can be utilized in session to train clients in the use of mindfulness techniques.
  14. Recognize common reactions to aversion and utilize clinical strategies to replace them with mindfulness.
  15. Reframe exposure as an opportunity to teach the amygdala new responses in order to improve client engagement and treatment compliance.
  16. Utilize clinical strategies for exposure that reduce avoidance and train clients to push through anxiety.
  17. Employ effective strategies for reducing anxiety symptoms utilizing imaginal and in vivo exposure, including use of SUDS and attention to interceptive triggers.
  18. Provide clinical strategies for managing comorbid depression that reduce worry, rumination, and common cognitive errors while promoting positive thinking and social interaction.
  19. Use cognitive restructuring and cognitive strategies for managing symptoms of OCD and GAD that focus on scheduling obsession/worries and promote client acceptance of uncertainty.
  20. Implement interventions in a clinical setting that use a reconsolidation approach to reactivate a symptom-producing memory and disconfirm it.

Outline

Module 4: Medications in the Treatment of Anxiety

Copyright : 06/30/2018

Module 5: Exposure Strategies for Teaching the Amygdala

Program Information

Objectives

  1. Explain to clients the neurological processes underlying anxiety in a clearly understandable manner that enhances client motivation.
  2. Incorporate personalized goals to increase client engagement and focus client efforts on making lasting changes in the brain.
  3. Characterize the differences between amygdala-based and cortex-based anxiety symptoms in order to select the most effective treatment interventions.
  4. Individualize practical and evidence-based methods to resist anxiety and improve symptom management in clients.
  5. Teach strategies for calming the amygdala without use of medication to improve client level of functioning.
  6. Recommend exposure-based strategies that change the amygdala responses to triggers to reduce anxiety symptoms.
  7. Employ a variety of strategies to improve clinical outcomes utilizing evidence-based strategies that target cortex-based responding, including cognitive restructuring, psychoeducation, cognitive defusion, distraction, and mindfulness.
  8. Differentiate symptom-producing cognitions characteristic of specific disorders, including Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder as it relates to case conceptualization.
  9. Relate the clinical implications of how SSRIs and SNRIs promote the process of treating anxiety.
  10. Identify detrimental effects of benzodiazepines as it relates to anxiety treatment outcomes.
  11. Differentiate between rebound anxiety and relapse symptoms to inform the clinician’s choice of treatment interventions.
  12. Breakdown the key elements of mindfulness practices in managing symptoms of anxiety.
  13. Present client education exercises that can be utilized in session to train clients in the use of mindfulness techniques.
  14. Recognize common reactions to aversion and utilize clinical strategies to replace them with mindfulness.
  15. Reframe exposure as an opportunity to teach the amygdala new responses in order to improve client engagement and treatment compliance.
  16. Utilize clinical strategies for exposure that reduce avoidance and train clients to push through anxiety.
  17. Employ effective strategies for reducing anxiety symptoms utilizing imaginal and in vivo exposure, including use of SUDS and attention to interceptive triggers.
  18. Provide clinical strategies for managing comorbid depression that reduce worry, rumination, and common cognitive errors while promoting positive thinking and social interaction.
  19. Use cognitive restructuring and cognitive strategies for managing symptoms of OCD and GAD that focus on scheduling obsession/worries and promote client acceptance of uncertainty.
  20. Implement interventions in a clinical setting that use a reconsolidation approach to reactivate a symptom-producing memory and disconfirm it.

Outline

Module 5: Exposure Strategies for Teaching the Amygdala

Copyright : 06/30/2018

Module 6: Mindfulness in the Anxious Brain

Program Information

Objectives

  1. Explain to clients the neurological processes underlying anxiety in a clearly understandable manner that enhances client motivation.
  2. Incorporate personalized goals to increase client engagement and focus client efforts on making lasting changes in the brain.
  3. Characterize the differences between amygdala-based and cortex-based anxiety symptoms in order to select the most effective treatment interventions.
  4. Individualize practical and evidence-based methods to resist anxiety and improve symptom management in clients.
  5. Teach strategies for calming the amygdala without use of medication to improve client level of functioning.
  6. Recommend exposure-based strategies that change the amygdala responses to triggers to reduce anxiety symptoms.
  7. Employ a variety of strategies to improve clinical outcomes utilizing evidence-based strategies that target cortex-based responding, including cognitive restructuring, psychoeducation, cognitive defusion, distraction, and mindfulness.
  8. Differentiate symptom-producing cognitions characteristic of specific disorders, including Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder as it relates to case conceptualization.
  9. Relate the clinical implications of how SSRIs and SNRIs promote the process of treating anxiety.
  10. Identify detrimental effects of benzodiazepines as it relates to anxiety treatment outcomes.
  11. Differentiate between rebound anxiety and relapse symptoms to inform the clinician’s choice of treatment interventions.
  12. Breakdown the key elements of mindfulness practices in managing symptoms of anxiety.
  13. Present client education exercises that can be utilized in session to train clients in the use of mindfulness techniques.
  14. Recognize common reactions to aversion and utilize clinical strategies to replace them with mindfulness.
  15. Reframe exposure as an opportunity to teach the amygdala new responses in order to improve client engagement and treatment compliance.
  16. Utilize clinical strategies for exposure that reduce avoidance and train clients to push through anxiety.
  17. Employ effective strategies for reducing anxiety symptoms utilizing imaginal and in vivo exposure, including use of SUDS and attention to interceptive triggers.
  18. Provide clinical strategies for managing comorbid depression that reduce worry, rumination, and common cognitive errors while promoting positive thinking and social interaction.
  19. Use cognitive restructuring and cognitive strategies for managing symptoms of OCD and GAD that focus on scheduling obsession/worries and promote client acceptance of uncertainty.
  20. Implement interventions in a clinical setting that use a reconsolidation approach to reactivate a symptom-producing memory and disconfirm it.

Outline

Module 6: Mindfulness in the Anxious Brain

Copyright : 06/30/2018

Module 7: Neuropsychologically Informed CBT

Program Information

Objectives

  1. Explain to clients the neurological processes underlying anxiety in a clearly understandable manner that enhances client motivation.
  2. Incorporate personalized goals to increase client engagement and focus client efforts on making lasting changes in the brain.
  3. Characterize the differences between amygdala-based and cortex-based anxiety symptoms in order to select the most effective treatment interventions.
  4. Individualize practical and evidence-based methods to resist anxiety and improve symptom management in clients.
  5. Teach strategies for calming the amygdala without use of medication to improve client level of functioning.
  6. Recommend exposure-based strategies that change the amygdala responses to triggers to reduce anxiety symptoms.
  7. Employ a variety of strategies to improve clinical outcomes utilizing evidence-based strategies that target cortex-based responding, including cognitive restructuring, psychoeducation, cognitive defusion, distraction, and mindfulness.
  8. Differentiate symptom-producing cognitions characteristic of specific disorders, including Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder as it relates to case conceptualization.
  9. Relate the clinical implications of how SSRIs and SNRIs promote the process of treating anxiety.
  10. Identify detrimental effects of benzodiazepines as it relates to anxiety treatment outcomes.
  11. Differentiate between rebound anxiety and relapse symptoms to inform the clinician’s choice of treatment interventions.
  12. Breakdown the key elements of mindfulness practices in managing symptoms of anxiety.
  13. Present client education exercises that can be utilized in session to train clients in the use of mindfulness techniques.
  14. Recognize common reactions to aversion and utilize clinical strategies to replace them with mindfulness.
  15. Reframe exposure as an opportunity to teach the amygdala new responses in order to improve client engagement and treatment compliance.
  16. Utilize clinical strategies for exposure that reduce avoidance and train clients to push through anxiety.
  17. Employ effective strategies for reducing anxiety symptoms utilizing imaginal and in vivo exposure, including use of SUDS and attention to interceptive triggers.
  18. Provide clinical strategies for managing comorbid depression that reduce worry, rumination, and common cognitive errors while promoting positive thinking and social interaction.
  19. Use cognitive restructuring and cognitive strategies for managing symptoms of OCD and GAD that focus on scheduling obsession/worries and promote client acceptance of uncertainty.
  20. Implement interventions in a clinical setting that use a reconsolidation approach to reactivate a symptom-producing memory and disconfirm it.

Outline

Module 7: Neuropsychologically Informed CBT

Copyright : 06/30/2018

Module 8: Treating Comorbid Depression

Program Information

Objectives

  1. Explain to clients the neurological processes underlying anxiety in a clearly understandable manner that enhances client motivation.
  2. Incorporate personalized goals to increase client engagement and focus client efforts on making lasting changes in the brain.
  3. Characterize the differences between amygdala-based and cortex-based anxiety symptoms in order to select the most effective treatment interventions.
  4. Individualize practical and evidence-based methods to resist anxiety and improve symptom management in clients.
  5. Teach strategies for calming the amygdala without use of medication to improve client level of functioning.
  6. Recommend exposure-based strategies that change the amygdala responses to triggers to reduce anxiety symptoms.
  7. Employ a variety of strategies to improve clinical outcomes utilizing evidence-based strategies that target cortex-based responding, including cognitive restructuring, psychoeducation, cognitive defusion, distraction, and mindfulness.
  8. Differentiate symptom-producing cognitions characteristic of specific disorders, including Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder as it relates to case conceptualization.
  9. Relate the clinical implications of how SSRIs and SNRIs promote the process of treating anxiety.
  10. Identify detrimental effects of benzodiazepines as it relates to anxiety treatment outcomes.
  11. Differentiate between rebound anxiety and relapse symptoms to inform the clinician’s choice of treatment interventions.
  12. Breakdown the key elements of mindfulness practices in managing symptoms of anxiety.
  13. Present client education exercises that can be utilized in session to train clients in the use of mindfulness techniques.
  14. Recognize common reactions to aversion and utilize clinical strategies to replace them with mindfulness.
  15. Reframe exposure as an opportunity to teach the amygdala new responses in order to improve client engagement and treatment compliance.
  16. Utilize clinical strategies for exposure that reduce avoidance and train clients to push through anxiety.
  17. Employ effective strategies for reducing anxiety symptoms utilizing imaginal and in vivo exposure, including use of SUDS and attention to interceptive triggers.
  18. Provide clinical strategies for managing comorbid depression that reduce worry, rumination, and common cognitive errors while promoting positive thinking and social interaction.
  19. Use cognitive restructuring and cognitive strategies for managing symptoms of OCD and GAD that focus on scheduling obsession/worries and promote client acceptance of uncertainty.
  20. Implement interventions in a clinical setting that use a reconsolidation approach to reactivate a symptom-producing memory and disconfirm it.

Outline

Module 8: Treating Comorbid Depression

Copyright : 06/30/2018

Module 9: Cognitive Restructuring Interventions

Program Information

Objectives

  1. Explain to clients the neurological processes underlying anxiety in a clearly understandable manner that enhances client motivation.
  2. Incorporate personalized goals to increase client engagement and focus client efforts on making lasting changes in the brain.
  3. Characterize the differences between amygdala-based and cortex-based anxiety symptoms in order to select the most effective treatment interventions.
  4. Individualize practical and evidence-based methods to resist anxiety and improve symptom management in clients.
  5. Teach strategies for calming the amygdala without use of medication to improve client level of functioning.
  6. Recommend exposure-based strategies that change the amygdala responses to triggers to reduce anxiety symptoms.
  7. Employ a variety of strategies to improve clinical outcomes utilizing evidence-based strategies that target cortex-based responding, including cognitive restructuring, psychoeducation, cognitive defusion, distraction, and mindfulness.
  8. Differentiate symptom-producing cognitions characteristic of specific disorders, including Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder as it relates to case conceptualization.
  9. Relate the clinical implications of how SSRIs and SNRIs promote the process of treating anxiety.
  10. Identify detrimental effects of benzodiazepines as it relates to anxiety treatment outcomes.
  11. Differentiate between rebound anxiety and relapse symptoms to inform the clinician’s choice of treatment interventions.
  12. Breakdown the key elements of mindfulness practices in managing symptoms of anxiety.
  13. Present client education exercises that can be utilized in session to train clients in the use of mindfulness techniques.
  14. Recognize common reactions to aversion and utilize clinical strategies to replace them with mindfulness.
  15. Reframe exposure as an opportunity to teach the amygdala new responses in order to improve client engagement and treatment compliance.
  16. Utilize clinical strategies for exposure that reduce avoidance and train clients to push through anxiety.
  17. Employ effective strategies for reducing anxiety symptoms utilizing imaginal and in vivo exposure, including use of SUDS and attention to interceptive triggers.
  18. Provide clinical strategies for managing comorbid depression that reduce worry, rumination, and common cognitive errors while promoting positive thinking and social interaction.
  19. Use cognitive restructuring and cognitive strategies for managing symptoms of OCD and GAD that focus on scheduling obsession/worries and promote client acceptance of uncertainty.
  20. Implement interventions in a clinical setting that use a reconsolidation approach to reactivate a symptom-producing memory and disconfirm it.

Outline

Module 9: Cognitive Restructuring Interventions

Copyright : 06/30/2018

Module 10: Using Re-consolidation Approaches

Program Information

Objectives

  1. Explain to clients the neurological processes underlying anxiety in a clearly understandable manner that enhances client motivation.
  2. Incorporate personalized goals to increase client engagement and focus client efforts on making lasting changes in the brain.
  3. Characterize the differences between amygdala-based and cortex-based anxiety symptoms in order to select the most effective treatment interventions.
  4. Individualize practical and evidence-based methods to resist anxiety and improve symptom management in clients.
  5. Teach strategies for calming the amygdala without use of medication to improve client level of functioning.
  6. Recommend exposure-based strategies that change the amygdala responses to triggers to reduce anxiety symptoms.
  7. Employ a variety of strategies to improve clinical outcomes utilizing evidence-based strategies that target cortex-based responding, including cognitive restructuring, psychoeducation, cognitive defusion, distraction, and mindfulness.
  8. Differentiate symptom-producing cognitions characteristic of specific disorders, including Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder as it relates to case conceptualization.
  9. Relate the clinical implications of how SSRIs and SNRIs promote the process of treating anxiety.
  10. Identify detrimental effects of benzodiazepines as it relates to anxiety treatment outcomes.
  11. Differentiate between rebound anxiety and relapse symptoms to inform the clinician’s choice of treatment interventions.
  12. Breakdown the key elements of mindfulness practices in managing symptoms of anxiety.
  13. Present client education exercises that can be utilized in session to train clients in the use of mindfulness techniques.
  14. Recognize common reactions to aversion and utilize clinical strategies to replace them with mindfulness.
  15. Reframe exposure as an opportunity to teach the amygdala new responses in order to improve client engagement and treatment compliance.
  16. Utilize clinical strategies for exposure that reduce avoidance and train clients to push through anxiety.
  17. Employ effective strategies for reducing anxiety symptoms utilizing imaginal and in vivo exposure, including use of SUDS and attention to interceptive triggers.
  18. Provide clinical strategies for managing comorbid depression that reduce worry, rumination, and common cognitive errors while promoting positive thinking and social interaction.
  19. Use cognitive restructuring and cognitive strategies for managing symptoms of OCD and GAD that focus on scheduling obsession/worries and promote client acceptance of uncertainty.
  20. Implement interventions in a clinical setting that use a reconsolidation approach to reactivate a symptom-producing memory and disconfirm it.

Outline

Module 10: Using Reconsolidation Approaches

Copyright : 06/30/2018

Module 1: Telehealth for Mental Health Professionals: Distance Therapy Training

The use of technology is a common expectation of clients in today’s world (and a requirement for some clients). Providing distance therapy services makes sense for your practice, but understanding all the legal, ethical, business and in-session challenges can seem daunting.

What are all the legal and ethical risks? Is distance therapy effective? How do I even get started? – Watch this recording and get the answers to your questions!

Providing distance therapy services will allow you to gain access to more clients and provide quality care for your clients wherever they are.

By completing this Distance Therapy Training Course, you’ll obtain a complete walkthrough of the whole process. You’ll learn:

This recording will leave you feeling confident in your ability to have a successful telehealth practice!

Program Information

Objectives

  1. Appraise the legal and ethical challenges posed by telehealth for mental health professionals in a clinical setting.
  2. Analyze the evidence supporting the effectiveness of telemental health as it relates to clinical treatment.
  3. Inspect the unique policies and procedures considerations for telehealth and the clinical implications.
  4. Evaluate adaptions with telemental health for various populations to improve clinical outcomes.
  5. Investigate the privacy, security and confidentiality concerns related to technology use in clinical practice.
  6. Differentiate how client expectations differ for telehealth as compared to in-person therapy and what that means for clinical treatment.
  7. Distinguish unique boundary issues that arise in a telemental health setting.
  8. Utilize specific adaptations that are recommended for various disorders and modalities to improve clinical outcomes.
  9. Appraise text messaging and email complications as it relates to privacy in a clinical setting.
  10. Apply best ethical practices regarding referrals and advertising concerns as it relates to clinical practice.
  11. Articulate the legalities of practicing across state lines via telemental health sessions.
  12. Specify the HIPAA compliance challenges associated with telemental health and its clinical implications.

Outline

Telehealth for Mental Health Professionals: What You Need to Know Before You Get Started

Legal & Ethical Issues How to Start Your Mental Health Telepractice Important Business Aspects to Consider Choosing a Platform – What Technology is Right for You and Your Clients? Demonstrations of Telehealth in Practice Additional Technology Considerations Treatment Adaptations to Consider for Telehealth Case Studies of Telehealth Successes & Failures The Future of Telehealth for Mental Health Professionals

Copyright : 02/20/2020

Module 2: Telehealth for Mental Health Professionals: Distance Therapy Training

Copyright : 02/20/2020